TY - JOUR
T1 - Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders
AU - Reed, Geoffrey M.
AU - First, Michael B.
AU - Kogan, Cary S.
AU - Hyman, Steven E.
AU - Gureje, Oye
AU - Gaebel, Wolfgang
AU - Maj, Mario
AU - Stein, Dan J.
AU - Maercker, Andreas
AU - Tyrer, Peter
AU - Claudino, Angelica
AU - Garralda, Elena
AU - Salvador-Carulla, Luis
AU - Ray, Rajat
AU - Saunders, John B.
AU - Dua, Tarun
AU - Poznyak, Vladimir
AU - Medina-Mora, María Elena
AU - Pike, Kathleen M.
AU - Ayuso-Mateos, José L.
AU - Kanba, Shigenobu
AU - Keeley, Jared W.
AU - Khoury, Brigitte
AU - Krasnov, Valery N.
AU - Kulygina, Maya
AU - Lovell, Anne M.
AU - de Jesus Mari, Jair
AU - Maruta, Toshimasa
AU - Matsumoto, Chihiro
AU - Rebello, Tahilia J.
AU - Roberts, Michael C.
AU - Robles, Rebeca
AU - Sharan, Pratap
AU - Zhao, Min
AU - Jablensky, Assen
AU - Udomratn, Pichet
AU - Rahimi-Movaghar, Afarin
AU - Rydelius, Per Anders
AU - Bährer-Kohler, Sabine
AU - Watts, Ann D.
AU - Saxena, Shekhar
N1 - Funding Information:
1Department of Mental Health and Substance Abuse,World Health Organization,Geneva,Switzerland;2Department of Psychiatry,Columbia University Medical Center,New York,NY,USA;3New York State Psychiatric Institute,New York,NY,USA;4School of Psychology,University of Ottawa,Ottawa,ON,Canada;5Stanley Center for Psychiatric Research, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA; 6Department of Psychiatry, University of Ibadan, Ibadan, Nigeria; 7Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; 8Department of Psychiatry, University of Campania “L. Vanvitelli”,Naples,Italy;9Department of Psychiatry,University of Cape Town,and South African Medical Research Council Unit on Risk and Resilience in Mental Disorders, Cape Town,South Africa;10Department of Psychology,University of Zurich,Zurich,Switzerland;11Centre for Mental Health,Imperial College,London,UK;12Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP/EPM), São Paulo, Brazil; 13Research School of Population Health, Australian National University, Canberra, ACT, Australia;14National Drug Dependence Treatment Centre,All India Institute of Medical Sciences,New Delhi,India;15Centre for Youth Substance Abuse Research,University of Queensland, Brisbane, QLD, Australia; 16National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico; 17Department of Psychiatry, Universidad Autonoma de Madrid; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); Instituto de Investigación Sanitaria La Princesa, Madrid, Spain; 18Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan; 19Department of Psychology,Virginia Commonwealth University, Richmond,VA, USA; 20Department of Psychiatry,American University of Beirut Medical Center,Beirut,Lebanon;21Moscow Research Institute of Psychiatry,National Medical Research Centre for Psychiatry and Narcology,Moscow,Russian Federation;22Institut National de la Santé et de la Recherche Médicale U988,Paris,France;23Health Management Center,Seitoku University, Matsudo, Japan; 24Japanese Society of Psychiatry and Neurology,Tokyo, Japan; 25Office of Graduate Studies and Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA; 26Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India; 27Shanghai Mental Health Center and Department of Psychiatry,Shanghai Jiao Tong University School of Medicine,Shanghai,People’s Republic of China;28Centre for Clinical Research in Neuropsychiatry,University of Western Australia,Perth,WA,Australia;29Department of Psychiatry,Prince of Songkla University,Hat Yai,Thailand;30Iranian National Center for Addiction Studies,Tehran University of Medical Sciences,Tehran,Iran;31Department of Child and Adolescent Psychiatry,Karolinska Institute,Stockholm,Sweden;32International Federation of Social Workers,Basel, Switzerland;33Entabeni Hospital,Durban,South Africa;34Harvard T.H.Chan School of Public Health,Boston,MA,USA
Publisher Copyright:
© 2019 World Psychiatric Association
PY - 2019/2
Y1 - 2019/2
N2 - Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11’s approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.
AB - Following approval of the ICD-11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD-10 to the ICD-11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders following ICD-11’s approval. The development of the ICD-11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD-11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture-related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery-based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD-11 classification of mental disorders as compared to the ICD-10, and the development of two new ICD-11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD-11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD-11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD-11 and in preparing for implementation in their own professional contexts.
KW - clinical utility
KW - culture-related guidance
KW - diagnosis
KW - dimensional approaches
KW - ICD-11
KW - International Classification of Diseases
KW - mental disorders
UR - http://www.scopus.com/inward/record.url?scp=85059384151&partnerID=8YFLogxK
U2 - 10.1002/wps.20611
DO - 10.1002/wps.20611
M3 - Article
AN - SCOPUS:85059384151
SN - 1723-8617
VL - 18
SP - 3
EP - 19
JO - World Psychiatry
JF - World Psychiatry
IS - 1
ER -